This study evaluates function, quality of life and development of hip- and knee osteoarthritis minimum 15 years after unilateral femoral lengthening on people with idiopathic or post-traumatic anisomelia.
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
hip or knee osteoarthritis
Timeframe: One day
Lower extremity strength
Timeframe: one day
Lower extremity function
Timeframe: one day
Aerob capasity
Timeframe: one day
measure of health related quality of life with EQ-5D-5L
Timeframe: one day
measure of function and pain with Knee Osteoarthritis Outcome Score (KOOS)
Timeframe: one day
measuring physical activity level with International Physical Activity Questionnaire (IPAQ)
Timeframe: one day
Active range of motion
Timeframe: one day